Document is current
Any future updates will be listed below
-
Authors
Zhao, Li
Zhou, Xuelei
Zhang, Ting
Mao, Wei
Chen, Linlin
Guo, Yiping
Liu, Xianchun
Zhang, Longyi
Li, Linji
-
Funding
Funding for this research was provided by:
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
the Nanchong Science and Technology Bureau (22SXQT0293)
- License Information
-
More Information
Article History
Received: 22 December 2024
Accepted: 19 March 2025
First Online: 7 April 2025
Declarations
:
: The authors declare no competing interests.
: This was an effective dose-finding study based on Dixon’s up-and-down method. The study was approved by the Ethics Committee of Nanchong Central Hospital (2024, trial (003) No.) and registered in the China Clinical Trial Registry (Registration time: 15/01/2025; Available at ; Registration Number: ChiCTR2500095959 ). We confirm that our research is consistent with the Declaration of Helsinki.
